A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

被引：0
|
作者：
Martin E Stryjewski
Arnold Lentnek
William O’Riordan
John Pullman
Paul Anantharajah Tambyah
Jose M Miró
Vance G Fowler Jr
Steven L Barriere
Michael M Kitt
G Ralph Corey
机构：
[1] Centro de Educación Médica e Investigaciones Clinicas (CEMIC) “Norberto Quirno”,Department of Medicine, Division of Infectious Diseases
[2] Wellstar Infectious Disease,Department of Medicine
[3] Mercury Street Medical Group,Infectious Diseases Service
[4] National University Health System,Department of Medicine, Division of Infectious Diseases
[5] Hospital Clinic–Institut d’investigacions Biomèdiques August Pi i Sunyer,undefined
[6] University of Barcelona,undefined
[7] Duke Clinical Research Institute,undefined
[8] Duke University Medical Center,undefined
[9] Theravance,undefined
[10] Inc,undefined
来源：
BMC Infectious Diseases | / 14卷
关键词：
Bacteremia; Telavancin; Vancomycin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
    Stryjewski, Martin E.
    Lentnek, Arnold
    O'Riordan, William
    Pullman, John
    Tambyah, Paul Anantharajah
    Miro, Jose M.
    Fowler, Vance G., Jr.
    Barriere, Steven L.
    Kitt, Michael M.
    Corey, G. Ralph
    BMC INFECTIOUS DISEASES, 2014, 14
  • [2] Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    Fowler, Vance G., Jr.
    Boucher, Helen W.
    Corey, G. Ralph
    Abrutyn, Elias
    Karchmer, Adolf W.
    Rupp, Mark E.
    Levine, Donald P.
    Chambers, Henry F.
    Tally, Francis P.
    Vigliani, Gloria A.
    Cabell, Christopher H.
    Link, Arthur Stanley
    DeMeyer, Ignace
    Filler, Scott G.
    Zervos, Marcus
    Cook, Paul
    Parsonnet, Jeffrey
    Bernstein, Jack M.
    Price, Connie Savor
    Forrest, Graeme N.
    Faetkenheuer, Gerd
    Gareca, Marcelo
    Rehm, Susan J.
    Brodt, Hans Reinhardt
    Tice, Alan
    Cosgrove, Sara E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 653 - 665
  • [3] Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    Fowler, V. G.
    Boucher, G. W.
    Corey, G. R.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) : 415 - 416
  • [4] Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
    Cheng, Matthew P.
    Lawandi, Alexander
    Butler-Laporte, Guillaume
    Paquette, Katryn
    Lee, Todd C.
    TRIALS, 2018, 19
  • [5] Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
    Matthew P. Cheng
    Alexander Lawandi
    Guillaume Butler-Laporte
    Katryn Paquette
    Todd C. Lee
    Trials, 19
  • [6] Daptomycin for the treatment of infective endocarditis: results from a randomized trial comparing daptomycin to standard therapy for Staphylococcus aureus bacteremia and infective endocarditis
    Kanafani, Z. A.
    Levine, D. P.
    Cabell, C. H.
    Fowler, V. G., Jr.
    Vigliani, G.
    Campion, M.
    Hoen, B.
    Miro, J. M.
    Corey, G. R.
    Boucher, H. W.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (06) : 423 - 423
  • [7] Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
    Louise Thorlacius-Ussing
    Christian Østergaard Andersen
    Niels Frimodt-Møller
    Inge Jenny Dahl Knudsen
    Jens Lundgren
    Thomas Lars Benfield
    Trials, 20
  • [8] Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
    Thorlacius-Ussing, Louise
    Andersen, Christian Ostergaard
    Frimodt-Moller, Niels
    Knudsen, Inge Jenny Dahl
    Lundgren, Jens
    Benfield, Thomas Lars
    TRIALS, 2019, 20 (1)
  • [9] Retrospective study to investigate appropriate duration of antibiotic treatment for uncomplicated Staphylococcus aureus bacteremia in patients with immunodeficiency
    Shibata, Yuichi
    Asai, Nobuhiro
    Hirai, Jun
    Mori, Nobuaki
    Hagihara, Mao
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (11) : 1141 - 1146
  • [10] Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
    Grillo, Sara
    Pujol, Miquel
    Miro, Josep M.
    Lopez-Contreras, Joaquin
    Euba, Gorane
    Gasch, Oriol
    Boix-Palop, Lucia
    Garcia-Pais, Maria Jose
    Perez-Rodriguez, Maria Teresa
    Gomez-Zorrilla, Silvia
    Oriol, Isabel
    Lopez-Cortes, Luis Eduardo
    Pedro-Botet, Maria Luisa
    San-Juan, Rafael
    Aguado, Jose Maria
    Gioia, Francesca
    Iftimie, Simona
    Morata, Laura
    Jover-Saenz, Alfredo
    Garcia-Pardo, Graciano
    Loeches, Belen
    Izquierdo-Cardenas, Alvaro
    Goikoetxea, Ane Josune
    Gomila-Grange, Aina
    Dietl, Beatriz
    Berbel, Damaris
    Videla, Sebastian
    Hereu, Pilar
    Padulles, Ariadna
    Pallares, Natalia
    Tebe, Cristian
    Cuervo, Guillermo
    Carratala, Jordi
    SAFO Study Grp
    NATURE MEDICINE, 2023, 29 (10) : 2518 - +
12345